Resectable Esophageal Squamous Cell Carcinoma Clinical Trials in Tianjin, Tianjin Municipality

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC